Key Details
Price
$27.07Annual ROE
45.26%Beta
0.87Events Calendar
Next earnings date:
Feb 28, 2025Recent quarterly earnings:
Nov 14, 2024Recent annual earnings:
N/ANext ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Jan 22, 25 HC Wainwright & Co.
BuyNov 15, 24 HC Wainwright & Co.
BuySep 11, 24 Citigroup
BuySep 10, 24 Oppenheimer
OutperformSep 10, 24 HC Wainwright & Co.
BuySep 10, 24 Goldman Sachs
BuyAug 16, 24 HC Wainwright & Co.
BuyAug 15, 24 Oppenheimer
OutperformJun 6, 24 HC Wainwright & Co.
BuyMay 9, 24 HC Wainwright & Co.
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
ArriVent BioPharma doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for ArriVent BioPharma?
- Does ArriVent BioPharma pay dividends?
- What sector is ArriVent BioPharma in?
- What industry is ArriVent BioPharma in?
- What country is ArriVent BioPharma based in?
- When did ArriVent BioPharma go public?
- Is ArriVent BioPharma in the S&P 500?
- Is ArriVent BioPharma in the NASDAQ 100?
- Is ArriVent BioPharma in the Dow Jones?
- When was ArriVent BioPharma's last earnings report?
- When does ArriVent BioPharma report earnings?
- Should I buy ArriVent BioPharma stock now?
What is the ticker symbol for ArriVent BioPharma?
The ticker symbol for ArriVent BioPharma is NASDAQ:AVBP
Does ArriVent BioPharma pay dividends?
No, ArriVent BioPharma does not pay dividends
What sector is ArriVent BioPharma in?
ArriVent BioPharma is in the Healthcare sector
What industry is ArriVent BioPharma in?
ArriVent BioPharma is in the Biotechnology industry
What country is ArriVent BioPharma based in?
ArriVent BioPharma is headquartered in United States
When did ArriVent BioPharma go public?
ArriVent BioPharma's initial public offering (IPO) was on January 26, 2024
Is ArriVent BioPharma in the S&P 500?
No, ArriVent BioPharma is not included in the S&P 500 index
Is ArriVent BioPharma in the NASDAQ 100?
No, ArriVent BioPharma is not included in the NASDAQ 100 index
Is ArriVent BioPharma in the Dow Jones?
No, ArriVent BioPharma is not included in the Dow Jones index
When was ArriVent BioPharma's last earnings report?
ArriVent BioPharma's most recent earnings report was on Nov 14, 2024
When does ArriVent BioPharma report earnings?
The next expected earnings date for ArriVent BioPharma is Feb 28, 2025
Should I buy ArriVent BioPharma stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions